Kenny Lim
Nov 26, 2008

Bates141 bags Merck business in Indonesia

JAKARTA - Global pharmaceutical firm Merck has appointed Bates141 for its estimated US$2 million creative business in Indonesia to develop communications for its portfolio of products in 2009.

Bates141 bags Merck business in Indonesia
The WPP firm bagged the account following strategy and creative presentations and has been tasked with repositioning vitamin supplements including Neurobion and Sangobion, which are popular over the counter brands, to a wider audience in Indonesia.

Other products in Bates’s remit include Becombion and Seven Seas. Merck had previously worked with DDB.

There are currently 29 international pharmaceutical companies marketing their products in Indonesia’s $2 billion pharmaceutical industry. Indonesian authorities have also recently imposed a ruling that requires foreign drug companies to establish local production facilities.

Related Articles

Just Published

5 hours ago

Reaping Jumbo profits: How brands see a niche in ...

How did an animated film about an orphan’s journey to find courage become Southeast Asia’s highest-grossing animation? Smart product placement and brand collaborations played a key role.

5 hours ago

How ASICS India is turning footprints into funnel ...

From gait scans to geo-targeted ads, the sporting goods group laces together tech, retail, and events to chase India’s growing base of runners.

2 days ago

Creative Minds: Gian Nealega is a believer in the ...

Grit, determination, persistence and a whole lot of creativity has helped Dentsu Creative Philippines Gian Nealega shift lanes from training to be a nurse to becoming a creative leader.